NJ Hemp Firms Work to Resolve Dispute Over New Law Last

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
156
NJ Hemp Firms Work to Resolve Dispute Over New Law

Last year, Governor Phil Murphy of New Jersey signed a controversial measure that would ban businesses in the state from selling hemp products without a marijuana license. This measure made it compulsory for all hemp businesses to apply for licenses through the Cannabis Regulatory Commission to distribute, manufacture, and sell hemp, a process that may take several months to complete. This is in addition to allowing holders of liquor licenses to sell hemp products if they acquired licenses from the commission.

The commission has overseen the state’s medicinal and recreational marijuana markets since medical and recreational sales became legal in 2010 and 2021 respectively.

Murphy explained that minors having access to these unregulated THC products was one of the main reasons legislators approved the measure, adding, however, that it did have some flaws. Soon after the ban went into effect, some hemp businesses appealed it in court, arguing that hemp was federally legal and the bill’s provisions were unconstitutionally vague.

Hemp has been legal at the federal level since the 2018 Farm Bill was approved, unlike marijuana, which is still classified as a Schedule I substance under the Controlled Substances Act.

In their defense, the businesses explained that state law effectively criminalized many hemp retail shop owners, manufacturers, and cultivators. U.S. District Court Judge Zahid N. Quraishi who presided over the case noted in his decision that while he sided with hemp businesses about some provisions infringing on interstate commerce unconstitutionally, he also agreed that the state had the power to regulate hemp.

In November, the commission announced that it couldn’t enforce provisions that dealt with the regulation of intoxicating hemp products. This decision, the commission noted, was based on the judge’s ruling.

However, it added, a ban on the sale of products that weren’t derived from naturally occurring active chemical constituents of hemp to individuals under age 21 was in effect and would be enforced. Under this law, individuals found selling intoxicating products derived from hemp without a license may pay up to $100 in fines for the 1st offense and $1000 for the 2nd offense. Any subsequent violations of this law will see individuals pay at least $10,000 in fines.

Currently, hemp companies are engaged in discussions that could resolve this dispute. Parties involved are required to file status reports every sixty days to the judge presiding over the case concerning potential developments in the bid to settle the case.

Hemp industry actors like Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) in other markets will be pleased that the different parties in New Jersey are opting to have discussions aimed at reaching a common position rather than fighting it out in the courts of law, which is very costly.

NOTE TO INVESTORS: The latest news and updates relating to Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) are available in the company’s newsroom at https://cnw.fm/SFWJ

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Software Effective (SFWJ) Stock Research Links

SFWJ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

OPay's IPO Launches: A $19 ADS Debut on NYSE

Updated Category News Views 28

Navigating the Waters of OPay's IPO Ah, the sweet smell of an IPO in the morning. Kicks off like a shot of espresso, doesn't it? Well, OPay's got coffee beans roasting with their IPO splash today. The digital financial platform, which has been shaking up the markets in Nigeria and beyond, announced they're selling 16 million American Depositary Shares (ADSs) at $19 a pop....

Continue Reading
Deciding Between Root Canal or Tooth Extraction

Updated Category News Views 89

The Battle Between Saving and Extracting Teeth No one really talks about teeth as if they hold the keys to happiness, but let’s face it, the difference between chewing a juicy steak and wincing with every bite can be the fate of a single tooth. Dr. Carey Norton from Dacula Family Dentistry breaks down when a root canal can be an oasis of hope and when extraction is the...

Continue Reading
Viatris Bids for Pacira: Strategic Healthcare Move

Updated Category News Views 41

Viatris Takes Strategic Step With Pacira Acquisition You ever notice how in the pharmaceutical games, it's not always the pills but the strategic moves that make the money? Viatris Inc., the global healthcare heavyweight, has just rolled the dice. They've initiated a tender offer to acquire Pacira BioSciences, a player in the non-opioid pain management market. Here's the...

Continue Reading
JAS Hits Top 1% in EcoVadis Sustainability Rankings

Updated Category News Views 101

A Platinum Performance in EcoVadis Ratings JAS Worldwide, hustling around in the logistics and supply chain sector, just nailed a spot in the much-coveted top 1% bracket for sustainability according to EcoVadis. We’re talking about a company that’s not only steering the mammoth ships of logistics but now it’s also wearing sustainability like a crown. This...

Continue Reading
MadaLuxe Snags DUXIANA in North American Expansion

Updated Category News Views 60

MadaLuxe's Bold Step into Luxury Sleep Here's a twist in the luxury game: MadaLuxe Group has grabbed the reins of DUXIANA's North American distribution business. If you haven't run into this iconic Swedish brand yet, it's been peddling high-end beds for a good century. Yep, 100 years of Swedish craftsmanship now in the pocket of MadaLuxe. They didn't spill any beans on...

Continue Reading
TDS and Array Set for Q3 Results Amid Market Curiosity

Updated Category News Views 30

The Anticipation Builds for TDS and Array's Q3 Results Financial markets are buzzing like a caffeine-fueled trading floor about the upcoming third quarter results from Telephone and Data Systems, Inc. (NYSE: TDS) and its partner in digital endeavors, Array Digital Infrastructure, Inc. (NYSE: AD). Set to go live with their numbers on November 6, 2026, these companies are...

Continue Reading
Bybit Unveils Platform Vision at HK FinTech Week

Updated Category News Views 52

Bybit's Strategic Participation at HK FinTech Week Here’s what’s got everyone buzzing: Bybit is stepping onto the big stage at the Hong Kong FinTech Week 2026. We're talking about the crème de la crème of fintech gatherings, where the sharpest minds of the financial world mingle, munch, and strategize under the buzzing neon of Hong Kong. Bybit's involvement is no...

Continue Reading
Royal Princess Docks New Features for Onboard Experience

Updated Category News Views 89

Royal Princess Sets Sail Refreshed Ever imagine what goes on behind the scenes of a full-blown ship makeover? Well, the Royal Princess just strutted out of a two-week stint in the drydock like a queen in a new frock. This ain't just slapping a fresh coat of paint on the hull. We're talking the debut of the Sanctuary Collection, a whole new gamut of spots for guests to wet...

Continue Reading
WesternU's Big Night: Boosting Lebanon’s Health Hub

Updated Category News Views 16

Building Bridges in Healthcare: WesternU's Strategic Move Heck, you know it's the real deal when a university throws a dinner party to celebrate partnerships. Western University of Health Sciences (WesternU) decided to clink glasses with Lebanon community leaders, hammering home the importance of their collaboration on October 6, 2026. Now, don't think this was just some...

Continue Reading
European Doctors Explore Chinese Aesthetic Innovations

Updated Category News Views 39

Pioneering Exchange in Regenerative Aesthetics Ever seen European doctors flocking to China to learn about beauty techniques? That's the scene as aphranel®, the brainchild of MOYOM Biotech, ushers in a week-long clinical exchange under 'The Norns' Weave.' The whole deal aims to unravel how Chinese practices could shape Europe's aesthetic landscape. Yep, it's all about...

Continue Reading

Top 5 Most Recently Viewed Articles

Hematology Analyzers Market Growth Projections to 2034

Updated Category News Views 173

Hematology Analyzers Market Growth Potential The global hematology analyzers market is witnessing impressive growth, anticipated to reach approximately USD 7.28 billion by 2034 from a previous valuation of USD 4.08 billion in 2024. This growth, representing an impressive CAGR of 5.97%, can be attributed to several key factors including the rise in blood-related disorders,...

Continue Reading
Interlune Secures $4.8 Million Grant for Lunar Research Facility

Updated Category News Views 677

Interlune Announces New Research Facility in Texas Interlune, a pioneering natural resources company, has officially disclosed its ambitious project of creating a Lunar Regolith Simulant Center of Excellence. With the support of a generous grant of up to $4.84 million from the Texas Space Commission (TSC), Interlune is set to establish a facility dedicated to the...

Continue Reading
Protiviti's Leadership Shifts Mark Next Growth Phase

Updated Category News Views 45

Leadership Shake-ups at Protiviti: A Strategic Move The winds of change are blowing at Protiviti, Robert Half’s consulting arm. Come January 1, 2027, Joe Tarantino, the seasoned skipper of this ship, is stepping away from the helm. After pouring two decades of leadership into the firm, he’s sliding sideways into a senior managing director role. Meanwhile, Cory...

Continue Reading
Clarivate Reports Disappointing Q3 2024 Financial Performance

Updated Category News Views 150

Clarivate Releases Third Quarter Financial Results Clarivate Plc (NYSE: CLVT), a prominent global provider of transformative intelligence, has released its financial results for the third quarter of 2024, revealing unsatisfactory performance. The company reported total revenues of $622.2 million, indicating a decrease of 3.9% compared to the previous year. The decline in...

Continue Reading
Stride's Legal Troubles: Unveiling the Truth Behind Its Stock Drop

Updated Category News Views 116

Understanding Stride's Legal Challenges Marketing its educational services, Stride, Inc. (NYSE: LRN) is presently embroiled in serious legal issues that stem from claims of securities fraud. Investors have been alarmed by the allegations that Stride misrepresented key operational figures, particularly regarding enrollment statistics. The ongoing class action lawsuit...

Continue Reading